COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 177 filers reported holding COHERUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,981,891 | +37.4% | 797,297 | +56.9% | 0.00% | +100.0% |
| Q2 2023 | $2,169,599 | -63.5% | 508,103 | -41.6% | 0.00% | -75.0% |
| Q1 2023 | $5,946,101 | -2.1% | 869,313 | +13.3% | 0.00% | -20.0% |
| Q4 2022 | $6,075,306 | -24.5% | 767,084 | -8.4% | 0.01% | -16.7% |
| Q3 2022 | $8,050,000 | +44.5% | 837,715 | +8.8% | 0.01% | +50.0% |
| Q2 2022 | $5,572,000 | -37.0% | 769,700 | +12.4% | 0.00% | -20.0% |
| Q1 2022 | $8,840,000 | -30.3% | 684,792 | -13.8% | 0.01% | -28.6% |
| Q4 2021 | $12,679,000 | +22.7% | 794,396 | +23.5% | 0.01% | +16.7% |
| Q3 2021 | $10,337,000 | -12.5% | 643,200 | -24.7% | 0.01% | -14.3% |
| Q2 2021 | $11,815,000 | +3.4% | 854,309 | +9.2% | 0.01% | 0.0% |
| Q1 2021 | $11,432,000 | +17.5% | 782,498 | +39.8% | 0.01% | +16.7% |
| Q4 2020 | $9,732,000 | +0.6% | 559,925 | +6.2% | 0.01% | 0.0% |
| Q3 2020 | $9,670,000 | +13.4% | 527,295 | +10.5% | 0.01% | -14.3% |
| Q2 2020 | $8,526,000 | +596.6% | 477,394 | +532.4% | 0.01% | +600.0% |
| Q1 2020 | $1,224,000 | +56.9% | 75,489 | +74.3% | 0.00% | 0.0% |
| Q4 2019 | $780,000 | -56.0% | 43,299 | -50.5% | 0.00% | 0.0% |
| Q3 2019 | $1,773,000 | -7.5% | 87,528 | +0.9% | 0.00% | -50.0% |
| Q2 2019 | $1,917,000 | +47.1% | 86,757 | -9.2% | 0.00% | +100.0% |
| Q1 2019 | $1,303,000 | +17.8% | 95,560 | -21.9% | 0.00% | 0.0% |
| Q4 2018 | $1,106,000 | +39.8% | 122,296 | +154.8% | 0.00% | 0.0% |
| Q3 2018 | $791,000 | -67.4% | 47,992 | -72.3% | 0.00% | -50.0% |
| Q2 2018 | $2,428,000 | +58.8% | 173,425 | +25.3% | 0.00% | +100.0% |
| Q1 2018 | $1,529,000 | +301.3% | 138,434 | +219.5% | 0.00% | – |
| Q4 2017 | $381,000 | -13.4% | 43,331 | +31.0% | 0.00% | – |
| Q3 2017 | $440,000 | -13.6% | 33,071 | -6.8% | 0.00% | – |
| Q2 2017 | $509,000 | +307.2% | 35,467 | +500.0% | 0.00% | – |
| Q1 2017 | $125,000 | -92.4% | 5,911 | -89.8% | 0.00% | -100.0% |
| Q4 2016 | $1,635,000 | +171.1% | 58,068 | +158.1% | 0.00% | 0.0% |
| Q3 2016 | $603,000 | +105.1% | 22,497 | +29.0% | 0.00% | – |
| Q2 2016 | $294,000 | -19.0% | 17,433 | +2.1% | 0.00% | – |
| Q1 2016 | $363,000 | +170.9% | 17,082 | +194.1% | 0.00% | – |
| Q4 2015 | $134,000 | – | 5,809 | +72512.5% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 8 | -97.8% | 0.00% | – |
| Q2 2015 | $11,000 | -98.1% | 359 | -98.1% | 0.00% | -100.0% |
| Q1 2015 | $577,000 | +2522.7% | 18,866 | +1281.1% | 0.00% | – |
| Q4 2014 | $22,000 | – | 1,366 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |